Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 47 results.
User Information
Export Records
  1. 1.   An NMR strategy for fragment-based ligand screening utilizing a paramagnetic lanthanide probe
  2. Saio, T.; Ogura, K.; Shimizu, K.; Yokochi, M.; Burke, T. R.; Inagaki, F.
  3. Journal of Biomolecular Nmr. 2011, Nov; 51(3): 395-408.
  1. 2.   LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?
  2. Orr, S. J.; McVicar, D. W.
  3. Journal of Leukocyte Biology. 2011, Jan; 89(1): 11-19.
  1. 3.   Identification of Shc Src Homology 2 Domain-Binding Peptoid-Peptide Hybrids
  2. Choi, W. J.; Kim, S. E.; Stephen, A. G.; Weidlich, I.; Giubellino, A.; Liu, F.; Worthy, K. M.; Bindu, L.; Fivash, M. J.; Nicklaus, M. C.; Bottaro, D. P.; Fisher, R. J.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2009 52(6): 1612-1618.
  1. 4.   Selectivity and Mechanism of Action of a Growth Factor Receptor-Bound Protein 2 Src Homology 2 Domain Binding Antagonist
  2. Giubellino, A.; Shi, Z. D.; Jenkins, L.; Worthy, K. M.; Bindu, L. K.; Athauda, G.; Peruzzi, B.; Fisher, R. J.; Appella, E.; Burke, T. R.; Bottaro, D. P.
  3. Journal of Medicinal Chemistry. 2008 51(23): 7459-7468.
  1. 5.   Preparation of orthogonally-protected 3-methoxy-4-phosphonomethyl-L-phenylalanine, a new reagent for the synthesis of phosphotyrosyl mimetic-containing peptides
  2. Choi, W. J.; Xang, S. U.; Burke, T. R.
  3. Letters in Organic Chemistry. 2007, Sep; 4(6): 433-439.
  1. 6.   Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist
  2. Giubellino, A.; Gao, Y.; Lee, S. M.; Lee, M. J.; Vasselli, J. R.; Medepalli, S.; Trepel, J. B.; Burke, T. R.; Bottaro, D. P.
  3. Cancer Research. 2007, Jul; 67(13): 6012-6016.
  1. 7.   Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain
  2. Spuches, A. M.; Argiros, H. J.; Lee, K. H.; Haas, L. L.; Perch, S. C.; Krag, D. N.; Roller, P. P.; Wilcox, D. E.; Lyons, B. A.
  3. Journal of Molecular Recognition. 2007, Jul-Aug; 20(4): 245-252.
  1. 8.   Structure-based design of potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics
  2. Jiang, S.; Li, P.; Peach, M. L.; Bindu, L.; Worthy, K. W.; Fisher, R. J.; Burke, T. R.; Nicklaus, M.; Roller, P. P.
  3. Biochemical and Biophysical Research Communications. 2006, Oct; 349(2): 497-503.
  1. 9.   Application of azide-alkyne cycloaddition 'click chemistry' for the synthesis of Grb2 SH2 domain-binding macrocycles
  2. Choi, W. J.; Shi, Z. D.; Worthy, K. M.; Bindu, L.; Karki, R. G.; Nicklaus, M. C.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2006, Oct; 16(20): 5265-5269.
  1. 10.   Gab1 is required for cell cycle transition, cell proliferation, and transformation induced by an oncogenic Met receptor
  2. Mood, K.; Saucier, C.; Bong, Y. S.; Lee, H. S.; Park, M.; Daar, I. O.
  3. Molecular Biology of the Cell. 2006, Sep; 17(9): 3717-3728.
  1. 11.   Design and concise synthesis of fully protected analogues of L-gamma-carboxyglutamic acid
  2. Jiang, S.; Li, P.; Lai, C. C.; Kelley, J. A.; Roller, P. P.
  3. Journal of Organic Chemistry. 2006, Sep; 71(19): 7307-7314.
  1. 12.   Oncogenic Met receptor induces ectopic structures in Xenopus embryos
  2. Ishimura, A.; Lee, H. S.; Bong, Y. S.; Saucier, C.; Mood, K.; Park, E.; Daar, I. O.
  3. Oncogene. 2006, Jul; 25(31): 4286-4299.
  1. 13.   Oncogenic met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling
  2. Mood, K.; Saucier, C.; Ishimura, A.; Bong, Y. S.; Lee, H. S.; Park, M.; Daar, I. O.
  3. Journal of Cellular Physiology. 2006, APR; 207(1): 271-285.
  1. 14.   Development of Grb2 SH2 domain signaling antagonists: A potential new class of antiproliferative agents
  2. Burke, T. R.
  3. International Journal of Peptide Research and Therapeutics. 2006, Mar; 12(1): 33-48.
  1. 15.   A practical synthesis of fully protected L-gamma-carboxyglutamic acid
  2. Jiang, S.; Lai, C. C.; Kelley, J. A.; Roller, P. P.
  3. Tetrahedron Letters. 2006, Jan; 47(1): 23-25.
  1. 16.   Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domain
  2. Phan, J.; Shi, Z. D.; Burke, T. R.; Waugh, D. S.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 104-115.
  1. 17.   Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinity
  2. Shi, Z. D.; Liu, H. P.; Zhang, M. C.; Worthy, K. M.; Bindu, L.; Yang, D. J.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry. 2005, JUL 1; 13(13): 4200-4208.
  1. 18.   Examination of phosphoryl-mimicking functionalities within a macrocyclic Grb2 SH2 domain-binding platform
  2. Kang, S. U.; Shi, Z. D.; Worthy, K. M.; Bindu, L. K.; Dharmawardana, P. G.; Choyke, S. J.; Bottaro, D. P.; Fisher, R. J.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2005, JUN 16; 48(12): 3945-3948.
  1. 19.   Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin
  2. Shi, Y. H.; Song, Y. L.; Lin, D. H.; Tan, J. Z.; Roller, P. P.; Li, Q.; Long, Y. Q.; Song, G. Q.
  3. Biochemical and Biophysical Research Communications. 2005, MAY 20; 330(4): 1254-1261.
  1. 20.   Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocycles
  2. Oishi, S.; Shi, Z. D.; Worthy, K. M.; Bindu, L. K.; Fisher, R. J.; Burke, T. R.
  3. Chembiochem. 2005, APR; 6(4): 668-674.
  1. 21.   Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic
  2. Shi, Z. D.; Karki, R. G.; Oishi, S.; Worthy, K. M.; Bindu, L. K.; Dharmawardana, P. G.; Nicklaus, M. C.; Bottaro, D. P.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2005, MAR 1; 15(5): 1385-1388.
  1. 22.   Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics
  2. Oishi, S.; Karki, R. G.; Kang, S. U.; Wang, X. Z.; Worthy, K. M.; Bindu, L. K.; Nicklaus, M. C.; Fisher, R. J.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2005, FEB 10; 48(3): 764-772.
  1. 23.   Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic
  2. Oishi, S.; Karki, R. G.; Shi, Z. D.; Worthy, K. M.; Bindu, L.; Chertov, O.; Esposito, D.; Frank, P.; Gillette, W. K.; Maderia, M.; Hartley, J.; Nicklaus, M. C.; Barchi, J. J.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry. 2005 13(7): 2431-2438.
  1. 24.   Utilization of a common pathway for the synthesis of high affinity macrocyclic Grh2 SH2 domain-binding peptide mimetics that differ in the configuration at one ring junction
  2. Shi, Z. D.; Karki, R. G.; Worthy, K. M.; Bindu, L. K.; Nicklaus, M. C.; Fisher, R. J.; Burke, T. R.
  3. Chemistry & Biodiversity. 2005 2(4): 447-456.
  1. 25.   Small nonphosphorylated Grb2-SH2 domain antagonists evaluated by surface resonance plasmon technology
  2. Lung, F. D. T.; Chang, C. W.; Chong, M. C.; Liou, C. C.; Li, P.; Peach, M. L.; Nicklaus, M. C.; Lou, B. S.; Roller, P. P.
  3. Peptide Science (Biopolymers). 2005 80(5): 628-635.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel